$181 Million is the total value of Sio Capital Management, LLC's 49 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 428.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KURA | Buy | KURA ONCOLOGY INC | $15,244,000 | +23.7% | 837,604 | +27.4% | 8.43% | +13.8% |
| HCA | Buy | HCA HEALTHCARE INC | $9,976,000 | +96.5% | 97,230 | +85.8% | 5.52% | +80.9% |
| MEIP | Buy | MEI PHARMA INC | $8,605,000 | +344.7% | 2,183,986 | +133.7% | 4.76% | +309.1% |
| ICLR | Buy | ICON PLC | $7,333,000 | +71.5% | 55,332 | +52.9% | 4.05% | +57.7% |
| AET | Buy | AETNA INC | $7,181,000 | +34.3% | 39,135 | +23.7% | 3.97% | +23.6% |
| DB | New | DEUTSCHE BANK AGput | $6,954,000 | – | 654,800 | +100.0% | 3.84% | – |
| CI | New | CIGNA CORP | $6,662,000 | – | 39,200 | +100.0% | 3.68% | – |
| CAH | New | CARDINAL HEALTH INC | $6,190,000 | – | 126,770 | +100.0% | 3.42% | – |
| HUM | New | HUMANA INC | $5,296,000 | – | 17,793 | +100.0% | 2.93% | – |
| PHG | Buy | KONINKLIJKE PHILIPS NVny reg sh new | $4,301,000 | +46.3% | 101,742 | +32.6% | 2.38% | +34.6% |
| NVS | New | NOVARTIS AGsponsored adr | $4,155,000 | – | 55,000 | +100.0% | 2.30% | – |
| RIGL | New | RIGEL PHARMACEUTICALS INC | $3,958,000 | – | 1,398,618 | +100.0% | 2.19% | – |
| WLTW | New | WILLIS TOWERS WATSON PLC | $3,937,000 | – | 25,969 | +100.0% | 2.18% | – |
| UHS | New | UNIVERSAL HEALTH SERVICES INCcl b | $3,936,000 | – | 35,323 | +100.0% | 2.18% | – |
| PKI | New | PERKINELMER INC | $3,853,000 | – | 52,620 | +100.0% | 2.13% | – |
| PFE | New | PFIZER INCput | $3,628,000 | – | 100,000 | +100.0% | 2.01% | – |
| MYL | New | MYLAN NVcall | $3,614,000 | – | 100,000 | +100.0% | 2.00% | – |
| ECOR | New | ELECTROCORE, INC. | $3,523,000 | – | 213,400 | +100.0% | 1.95% | – |
| CELG | Buy | CELGENE CORP | $3,331,000 | +19.7% | 41,942 | +34.5% | 1.84% | +10.2% |
| SPPI | New | SPECTRUM PHARMACEUTICALS INC | $3,009,000 | – | 143,550 | +100.0% | 1.66% | – |
| MRTX | New | MIRATI THERAPEUTICS INC | $2,960,000 | – | 60,050 | +100.0% | 1.64% | – |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $2,938,000 | – | 29,835 | +100.0% | 1.62% | – |
| INCY | New | INCYTE CORP | $2,814,000 | – | 42,000 | +100.0% | 1.56% | – |
| RVNC | New | REVANCE THERAPEUTICS INC | $2,780,000 | – | 101,292 | +100.0% | 1.54% | – |
| MCK | New | MCKESSON CORP | $2,335,000 | – | 17,500 | +100.0% | 1.29% | – |
| RETA | New | REATA PHARMACEUTICALS INCcl a | $1,533,000 | – | 43,842 | +100.0% | 0.85% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $1,499,000 | – | 10,740 | +100.0% | 0.83% | – |
| PINC | New | PREMIER INCput | $1,455,000 | – | 40,000 | +100.0% | 0.80% | – |
| WST | New | WEST PHARMACEUTICAL SERVICES INCput | $1,400,000 | – | 14,100 | +100.0% | 0.77% | – |
| ZTS | New | ZOETIS INCput | $1,363,000 | – | 16,000 | +100.0% | 0.75% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $1,180,000 | – | 13,840 | +100.0% | 0.65% | – |
| PFNX | New | PFENEX INC | $1,025,000 | – | 189,519 | +100.0% | 0.57% | – |
| XLRN | New | ACCELERON PHARMA INCput | $810,000 | – | 16,700 | +100.0% | 0.45% | – |
| VSAR | New | VERSARTIS INC | $504,000 | – | 248,653 | +100.0% | 0.28% | – |
| CTIC | New | CTI BIOPHARMA CORPput | $157,000 | – | 31,600 | +100.0% | 0.09% | – |
| HSGX | New | HISTOGENICS CORP | $98,000 | – | 39,175 | +100.0% | 0.05% | – |
| VTL | New | VITAL THERAPIES INCput | $95,000 | – | 13,900 | +100.0% | 0.05% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2022-11-14 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.